BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

452 related articles for article (PubMed ID: 26765786)

  • 41. Cyclodextrins: Efficient biocompatible solubilizing excipients for bromhexine liquid and semi-solid drug delivery systems.
    Stojanov M; Nielsen HM; Larsen KL
    Int J Pharm; 2012 Jan; 422(1-2):349-55. PubMed ID: 22027391
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Modified thermoresponsive Poloxamer 407 and chitosan sol-gels as potential sustained-release vaccine delivery systems.
    Kojarunchitt T; Baldursdottir S; Dong YD; Boyd BJ; Rades T; Hook S
    Eur J Pharm Biopharm; 2015 Jan; 89():74-81. PubMed ID: 25481034
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Preparation and Spectroscopic Characterization of Inclusion Complexes of 3D Ball-Milled Rifampicin with β-cyclodextrin and γ-cyclodextrin : 3D Ball-Milled Rifampicin with β-cyclodextrin and γ-cyclodextrin.
    Inoue Y; Shigematsu M; Komatsu T; Oguchi T; Arce FJ; See GL
    AAPS PharmSciTech; 2022 May; 23(5):138. PubMed ID: 35534746
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Self-association of cyclodextrins and cyclodextrin complexes in aqueous solutions.
    Loftsson T; Saokham P; Sá Couto AR
    Int J Pharm; 2019 Apr; 560():228-234. PubMed ID: 30771468
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effect of γ-cyclodextrin on solubilization and complexation of irbesartan: influence of pH and excipients.
    Muankaew C; Jansook P; Stefánsson E; Loftsson T
    Int J Pharm; 2014 Oct; 474(1-2):80-90. PubMed ID: 25128698
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Poloxamer 407 based-nanoparticles for controlled release of methotrexate.
    Moura S; Noro J; Cerqueira P; Silva C; Cavaco-Paulo A; Loureiro A
    Int J Pharm; 2020 Feb; 575():118924. PubMed ID: 31870962
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Drug delivery to the ocular posterior segment using lipid emulsion via eye drop administration: effect of emulsion formulations and surface modification.
    Ying L; Tahara K; Takeuchi H
    Int J Pharm; 2013 Sep; 453(2):329-35. PubMed ID: 23796836
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Nanosuspensions Containing Oridonin/HP-β-Cyclodextrin Inclusion Complexes for Oral Bioavailability Enhancement via Improved Dissolution and Permeability.
    Zhang X; Zhang T; Lan Y; Wu B; Shi Z
    AAPS PharmSciTech; 2016 Apr; 17(2):400-8. PubMed ID: 26187778
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Characterization and Evaluation of Ternary Complexes of Ascorbic Acid with γ-Cyclodextrin and Poly(vinyl Alcohol).
    Saokham P; Burapapadh K; Praphanwittaya P; Loftsson T
    Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32575742
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Ester-Based Hydrophilic Cyclodextrin Nanosponges for Topical Ocular Drug Delivery.
    Hayiyana Z; Choonara YE; Makgotloe A; du Toit LC; Kumar P; Pillay V
    Curr Pharm Des; 2016; 22(46):6988-6997. PubMed ID: 27981908
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Formulation and optimization of nanoemulsion using antifungal lipid and surfactant for accentuated topical delivery of Amphotericin B.
    Hussain A; Singh VK; Singh OP; Shafaat K; Kumar S; Ahmad FJ
    Drug Deliv; 2016 Oct; 23(8):3101-3110. PubMed ID: 27854145
    [TBL] [Abstract][Full Text] [Related]  

  • 52. rhEGF/HP-beta-CD complex in poloxamer gel for ophthalmic delivery.
    Kim EY; Gao ZG; Park JS; Li H; Han K
    Int J Pharm; 2002 Feb; 233(1-2):159-67. PubMed ID: 11897420
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Aggregation of amphotericin B in the presence of gamma-cyclodextrin.
    Kajtár M; Vikmon M; Morlin E; Szejtli J
    Biopolymers; 1989 Sep; 28(9):1585-96. PubMed ID: 2775849
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Poloxamer/cyclodextrin/chitosan-based thermoreversible gel for intranasal delivery of fexofenadine hydrochloride.
    Cho HJ; Balakrishnan P; Park EK; Song KW; Hong SS; Jang TY; Kim KS; Chung SJ; Shim CK; Kim DD
    J Pharm Sci; 2011 Feb; 100(2):681-91. PubMed ID: 20803575
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Increasing the stability of curcumin in serum with liposomes or hybrid drug-in-cyclodextrin-in-liposome systems: a comparative study.
    Matloob AH; Mourtas S; Klepetsanis P; Antimisiaris SG
    Int J Pharm; 2014 Dec; 476(1-2):108-15. PubMed ID: 25269006
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Evaluation of γ-cyclodextrin effect on permeation of lipophilic drugs: application of cellophane/fused octanol membrane.
    Muankaew C; Jansook P; Loftsson T
    Pharm Dev Technol; 2017 Jun; 22(4):562-570. PubMed ID: 27146583
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Multifunctional nanocomposite eye drops of cyclodextrin complex@layered double hydroxides for relay drug delivery to the posterior segment of the eye.
    Xu C; Lu J; Zhou L; Liang J; Fang L; Cao F
    Carbohydr Polym; 2021 May; 260():117800. PubMed ID: 33712148
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cyclodextrin-based poly(pseudo)rotaxanes for transdermal delivery of carvedilol.
    Taveira SF; Varela-Garcia A; Dos Santos Souza B; Marreto RN; Martin-Pastor M; Concheiro A; Alvarez-Lorenzo C
    Carbohydr Polym; 2018 Nov; 200():278-288. PubMed ID: 30177168
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Nanoemulsion gel-based topical delivery of an antifungal drug: in vitro activity and in vivo evaluation.
    Hussain A; Samad A; Singh SK; Ahsan MN; Haque MW; Faruk A; Ahmed FJ
    Drug Deliv; 2016; 23(2):642-47. PubMed ID: 25013957
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cyclodextrin complexes of a globular protein and a lipophilic oligopeptide: the effect of structure and physicochemical properties.
    Jóhannsdóttir S; Saokham P; Magnúsdóttir A; Loftsson T
    Pharmazie; 2017 Oct; 72(10):575-580. PubMed ID: 29441881
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.